HHM Wealth Advisors LLC Purchases New Position in Encompass Health Co. (NYSE:EHC)

HHM Wealth Advisors LLC acquired a new position in shares of Encompass Health Co. (NYSE:EHC) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,700 shares of the company’s stock, valued at approximately $146,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. M&T Bank Corp purchased a new stake in Encompass Health during the fourth quarter valued at $201,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Encompass Health by 2.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 631,816 shares of the company’s stock valued at $42,155,000 after acquiring an additional 12,396 shares during the last quarter. Principal Securities Inc. purchased a new position in Encompass Health in the fourth quarter worth about $25,000. QRG Capital Management Inc. increased its stake in Encompass Health by 10.4% during the fourth quarter. QRG Capital Management Inc. now owns 6,271 shares of the company’s stock worth $418,000 after acquiring an additional 593 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Encompass Health by 12.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,764,092 shares of the company’s stock valued at $117,703,000 after purchasing an additional 190,860 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $91.72 on Thursday. The firm’s 50 day simple moving average is $89.01 and its 200-day simple moving average is $84.45. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35. Encompass Health Co. has a one year low of $57.55 and a one year high of $94.38. The firm has a market cap of $9.23 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 1.40 and a beta of 0.88.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, August 5th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.30 billion. During the same period last year, the business posted $0.95 EPS. Encompass Health’s quarterly revenue was up 9.6% on a year-over-year basis. As a group, equities analysts predict that Encompass Health Co. will post 4.17 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.74%. Encompass Health’s dividend payout ratio is 18.38%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on EHC shares. UBS Group boosted their target price on Encompass Health from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Leerink Partnrs raised shares of Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Barclays dropped their price target on shares of Encompass Health from $113.00 to $109.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Truist Financial increased their price objective on shares of Encompass Health from $100.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. Finally, Royal Bank of Canada boosted their target price on Encompass Health from $83.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $100.38.

Insider Buying and Selling at Encompass Health

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the sale, the chief financial officer now owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.